Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1

Status

Completed 5Withdrawn 3Terminated 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Histologically-confirmed Malignancies 1Brain Neoplasms 1Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment) 1

Interventions

Radiosurgery 20Magnetic Resonance Spectroscopy 20Exercise 15Biopsy 11Surveys and Questionnaires 9Standard of Care 9Cyclophosphamide 9Educational Status 8Practice Guidelines as Topic 7Doxorubicin 7Cisplatin 7Therapeutics 6Radiotherapy 6Methods 6Fluorodeoxyglucose F18 6Early Intervention, Educational 6Blood Specimen Collection 6Radiotherapy, Intensity-Modulated 5Electroporation 5Cryosurgery 5Colonoscopy 5X-Rays 4Water 4Vincristine 4Polymerase Chain Reaction 4Palliative Care 4Irinotecan 4Drug Therapy 4Diet Therapy 4Cryotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × alovudine × Clear all
NCT02139150 2019-09-17

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Memorial Sloan Kettering Cancer Center

Phase NA Withdrawn

Histologically-confirmed Malignancies

NCT02241668 2016-02-26

Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma

M.D. Anderson Cancer Center

Phase NA Withdrawn
CNS

Brain Neoplasms

NCT01018251 2015-12-15

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

Abramson Cancer Center at Penn Medicine

Phase NA Withdrawn
Breast

Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡